Pharmacokinetic and clinical data inform therapeutic selection for difficult to treat Pseudomonas aeruginosa CNS infections
New strategies help treat drug resistant brain infections
This narrative review evaluates the feasibility of various antimicrobial agents, including ceftolozane-tazobactam, ceftazidime-avibactam, az…
Doctors are finding new ways to treat serious brain infections caused by bacteria that have become hard to kill with standard medicine.
Review of Therapeutic Options for Carbapenem-Resistant Enterobacterales
New Weapons Emerge in the Fight Against Deadly Superbugs
This review summarizes available and emerging therapies for carbapenem-resistant Enterobacterales.
New drug combinations offer hope for patients facing deadly superbugs that resist almost all current antibiotics.